Ocular and cardiovascular response to topical carteolol 2% and timolol 0.5% in healthy volunteers.
Open Access
- 1 February 1988
- journal article
- research article
- Published by BMJ in British Journal of Ophthalmology
- Vol. 72 (2) , 101-103
- https://doi.org/10.1136/bjo.72.2.101
Abstract
Ocular and cardiovascular effects of carteolol 2%, timolol 0.5%, and dummy eyedrops have been measured in a single dose double-blind crossover study in six healthy volunteers. Both drugs lowered intraocular pressure and reduced exercise-induced tachycardia. Neither produced a significant change in resting heart rate or blood pressure. The two agents appear comparable as regards ocular hypotensive and cardiovascular effects.This publication has 6 references indexed in Scilit:
- Respiratory Difficulties With BetaxololAmerican Journal of Ophthalmology, 1986
- A Double-Masked Comparison of Betaxolol vs Timolol in the Treatment of Open-Angle GlaucomaAmerican Journal of Ophthalmology, 1986
- Betaxolol in Patients with Glaucoma and AsthmaAmerican Journal of Ophthalmology, 1986
- A blind randomised cross-over trial comparing metipranolol 0.3% with timolol 0.25% in open-angle glaucoma: a pilot study.British Journal of Ophthalmology, 1986
- Adverse Reactions from Timolol AdministrationOphthalmology, 1980
- POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MANThe Lancet, 1977